• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "BCL11A expression in acute phase chronic myeloid leukemia" [Leuk. Res. 47 (2016) 88-92].

作者信息

Yin Jiawei, Zhang Fan, Tao Huiquan, Ma Xiao, Su Guangsong, Xie Xiaoli, Xu Zhongjuan, Zheng Yanwen, Liu Hong, He Chao, Mao Zhengwei Jenny, Wang Zhiwei, Chang Weirong, Gale Robert Peter, Wu Depei, Yin Bin

机构信息

Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, Soochow University, Suzhou, Jiangsu Province, China.

The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou, Jiangsu Province, China.

出版信息

Leuk Res. 2017 Jan;52:67. doi: 10.1016/j.leukres.2016.08.001. Epub 2016 Nov 21.

DOI:10.1016/j.leukres.2016.08.001
PMID:27884397
Abstract
摘要

相似文献

1
Corrigendum to "BCL11A expression in acute phase chronic myeloid leukemia" [Leuk. Res. 47 (2016) 88-92].《“慢性髓系白血病急性期的BCL11A表达”勘误》[《白血病研究》47卷（2016年）第88 - 92页]
Leuk Res. 2017 Jan;52:67. doi: 10.1016/j.leukres.2016.08.001. Epub 2016 Nov 21.
2
BCL11A expression in acute phase chronic myeloid leukemia.BCL11A在慢性髓性白血病急性期的表达
Leuk Res. 2016 Aug;47:88-92. doi: 10.1016/j.leukres.2016.05.018. Epub 2016 May 24.
3
Corrigendum to "STAT5b-RARa-positive acute myeloid leukemia: Diagnostic and therapeutic challenges of a rare AML subtype" [Leuk. Res. 78 (2019) 21-23].
Leuk Res. 2020 Jun;93:106148. doi: 10.1016/j.leukres.2019.04.014. Epub 2020 May 4.
4
Corrigendum to "Prevalence of germline predisposition gene mutations in pediatric acute myeloid leukemia: Genetic background of pediatric AML" [Leuk. Res. 85 (2019) (October) 106210].
Leuk Res. 2019 Dec;87:106249. doi: 10.1016/j.leukres.2019.106249. Epub 2019 Oct 28.
5
Corrigendum to "Real-world clinical outcomes with enasidenib in relapsed or refractory acute myeloid leukemia" [Leuk. Res. (2022) 106946].
Leuk Res. 2024 Jan;136:107430. doi: 10.1016/j.leukres.2023.107430. Epub 2024 Jan 9.
6
High BCL11A Expression in Adult Acute Myeloid Leukemia Patients Predicts a Worse Clinical Outcome.成年急性髓系白血病患者中高BCL11A表达预示更差的临床结局。
Clin Lab. 2017 Jan 1;63(1):85-90. doi: 10.7754/Clin.Lab.2016.160614.
7
Corrigendum to "Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study" [Leuk. Res. 92 (March) (2020) 106352].
Leuk Res. 2020 Sep;96:106388. doi: 10.1016/j.leukres.2020.106388. Epub 2020 Jul 14.
8
BCL11A expression in acute myeloid leukemia.急性髓系白血病中BCL11A的表达
Leuk Res. 2016 Feb;41:71-5. doi: 10.1016/j.leukres.2015.12.001. Epub 2015 Dec 7.
9
Corrigendum to "Patient-driven research: Initial results from a prospective health-related quality of life study performed at the request of patients living with hairy cell leukemia" [Leuk. Res. 120 (2022) 106919].
Leuk Res. 2022 Oct;121:106943. doi: 10.1016/j.leukres.2022.106943. Epub 2022 Sep 2.
10
Corrigendum to "KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study" [Leuk. Res. 50 (Nov) (2016) 123-131. PubMed PMID: 27736729].
Leuk Res. 2017 Aug;59:65. doi: 10.1016/j.leukres.2017.02.007. Epub 2017 May 30.

引用本文的文献

1
BCL11A: a potential diagnostic biomarker and therapeutic target in human diseases.BCL11A：人类疾病潜在的诊断生物标志物和治疗靶点。
Biosci Rep. 2019 Nov 29;39(11). doi: 10.1042/BSR20190604.